Amylyx Pharmaceuticals at ObesityWeek 2026
Nov 14–17, 2026 National Harbor, MD ~4.4k attendees Website
Amylyx Pharmaceuticals brings 3 presentations to ObesityWeek 2026 in National Harbor, and exhibits at Booth 701, Suite 1. Its program centres on post-bariatric hypoglycemia, the low blood sugar that can follow weight-loss surgery. One study uses US insurance claims data to find people with the condition, and the company also hosts a reception.
| Organization | ObesityWeek 2026 Attendance |
|---|---|
Amylyx Pharmaceuticals Cambridge, MA | ◇Bronze Sponsor |
Develops investigational therapies for endocrine and neurodegenerative conditions, including treatment for hypoglycemia after bariatric surgery. | Booth Exhibiting at Booth 701, Suite 1 Sat, Nov 147pm–9:30pmSun, Nov 159:30am–4pmMon, Nov 169:30am–4pm Session Sun Nov 15 5:30pm–8:00pm Session Mon Nov 16 7:30am–8:30am Poster Mon Nov 16 2:30pm–3:30pm Identification of Individuals With Post-Bariatric Hypoglycemia in US Claims Data: Insights and Opportunities Population health and epidemiology |
Find decision makers at Amylyx Pharmaceuticals
Tell us what you sell and we’ll find the people at Amylyx Pharmaceuticals most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by The Obesity Society (TOS), ObesityWeek® or the American Society for Metabolic and Bariatric Surgery (ASMBS). Submit a correction